![]() |
市场调查报告书
商品编码
1825961
2025年生医光电全球市场报告Biophotonics Global Market Report 2025 |
近年来,生医光电市场快速扩张,从2024年的832.6亿美元成长到2025年的920.7亿美元,复合年增长率为10.6%。过去一段时间的增长得益于医学成像、疾病诊断和监测、生命科学研究、光学感测和光谱学以及雷射和光源技术的创新。
预计未来几年生医光电市场规模将快速成长,到2029年将达到1,478.4亿美元,复合年增长率为12.6%。预测期内的成长可归因于个人化医疗、精密农业、全球健康倡议、穿戴式和行动医疗设备、环境监测和安全。预测期内的主要趋势包括微型化和照护现场设备、多模态成像、光遗传学、机器学习和数据分析以及智慧成像探针。
生医光电代表了光电与生物学的融合,形成了一个专注于光技术在生命科学和医学领域应用的跨学科研究领域。其主要目标是在生物学领域内,从细胞、组织、分子和生物等多个层面研究、操控和监测生物过程。
生医光电的主要技术领域包括体外和体内技术。体外技术是指在微生物、细胞和生物分子的自然生物环境之外进行研究的方法。此类研究通常在实验室容器中进行,例如试管、烧瓶、培养皿和微量滴定板,通常称为试管研究。生医光电的各种应用包括透视成像、内部成像、光谱分子分析、表面成像、显微镜、光疗法和生物感测器,并广泛应用于诊断、治疗、检测及相关领域。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响,尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本,而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力,一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外,原料和零件的关税扰乱了关键药品和医疗设备的生产,导致供应链延迟。作为应对措施,该行业正在采用多样化的筹资策略,尽可能扩大本地生产,并游说对关键医疗产品免关税。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供生医光电市场统计数据,例如全球生医光电市场规模、各地区市场份额、生医光电竞争对手的市场份额、详细的生医光电市场细分、市场趋势和商业机会,以及您在生医光电行业取得成功所需的数据。本生医光电市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年12.6%的成长率预测比我们先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的医疗诊断业务,因为这会增加从日本和以色列进口的光学相干断层扫描系统和雷射手术器械的成本,从而可能降低手术的准确性并增加资本成本。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响,其影响也可能更为广泛。
由于微创手术需求的不断增长,生医光电市场正在经历显着成长。光学工程和成像技术的进步在增强微创手术方面发挥关键作用,使远端内部位置的组织操作能够即时可视化。例如,2023年1月,美国领先的机器人产品製造商Intuitive Surgical Inc.报告称,2022年使用Vinci Surgical Systems进行的手术约有1,875,000例,比2021年使用Vinci Surgical Systems进行的1,594,000例增长了18%。全球每年微创手术数量的增加直接推动了生医光电市场收益的成长。
预计生医光电市场的成长将受到慢性病盛行率上升的推动。慢性病的特征是持续性,持续时间超过三个月,并且在世界各地普遍存在。生医光电在这些疾病的早期发现、持续监测和有效治疗中发挥关键作用,提供非侵入性影像和诊断解决方案。这可以改善患者的治疗效果,同时控制医疗成本。根据世界卫生组织 (WHO) 2022 年 9 月发布的报告,慢性病占全球死亡人数的很大一部分,其中 74% 的死亡可归因于慢性病。这些慢性病包括各种疾病,例如心血管疾病、癌症、慢性呼吸系统疾病和糖尿病。因此,慢性病发生率的上升刺激了生医光电市场的成长。
推动生医光电市场发展的显着趋势之一是生物技术领域对先进技术的采用。苏格兰圣安德鲁斯大学的一支科学家团队发明了一种萤光显微镜技术。这种创新方法能够以最小的损伤对精细的生物样本进行成像,尤其是在神经科学和生物医学应用中。预计这种侵入性较小的光学技术将在不久的将来彻底改变生物医学领域。因此,生医光电市场对新兴尖端技术的重视程度日益提升。
生医光电市场的主要企业正专注于开发先进的技术解决方案,例如尖端运算工具,以提高成像精度、增强诊断能力并支援个人化医疗。尖端计算工具是专门的软体和演算法,旨在分析来自医学影像和分子诊断等领域的复杂数据。这些工具利用机器学习和人工智慧,提高了生医光电应用的精确度和效率。例如,2023 年 7 月,美国生物技术公司 FOXO Technologies Inc. 推出了旨在变革表观遗传学数据分析的生物资讯服务。这些服务提供了一个全面的平台,旨在满足学术、医疗保健和製药行业客户的需求。关键发展包括原始 DNA 甲基化微阵列数据的处理和分析以及高级分析,例如表观基因组关联研究 (EWAS) 和人工智慧主导的表观遗传生物标记开发。
2024年5月,美国製造公司布鲁克公司(Bruker Corporation)以3.926亿美元收购了NanoString Technologies。此次收购增强了布鲁克在太空生物学领域的能力,尤其是其nCounter分析系统,能够灵敏、准确地分析基因和蛋白质的表达。 NanoString Technologies是美国的生命科学工具供应商,致力于转化研究和分子诊断。
生医光电市场的主要企业包括赛默飞世尔科技公司、OpGen公司、NU Skin Enterprises公司、IPG Photonics公司、Idex公司、东芝公司、堀场製作所、Precision Photonics公司、罗氏集团、通用电气公司、荷兰皇家飞利浦公司、Affymeas、AndEIortrix、Fenam、Bamak、Mam 这些公司、Fenam、Ftidamone、B.Senk、Yamuid参与公司、H两身公司、Af 这些公司、Henam、Funamidet. Photonics公司、Lumenis公司、奥林巴斯公司、PerkinElmer公司、Zecotek Photonics公司、Zenalux Biomedical公司、Glenbrook Technologies公司、Oxford Instruments公司、Lumicks公司、Creoptix公司、ThinkCyte公司、PhotoPharmics公司、Impedimedcks公司和Bioptics公司。
2024年,生医光电市场最大的地区是北美。西欧是生医光电市场的第二大地区。生医光电市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。
生医光电市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。
Biophotonics represents the convergence of photonics and biology, forming a multidisciplinary research field focused on the application of light-based technologies in life sciences and medical domains. Its primary purpose is to investigate, manipulate, and monitor biological processes at multiple levels within the realm of biology, spanning cellular, tissue, molecular, and organismic aspects.
The key technological segments in biophotonics involve in-vitro and in-vivo methodologies. In-vitro approaches are centered around the examination of microorganisms, cells, and biological molecules outside of their natural biological environments. These investigations are typically conducted in laboratory vessels like test tubes, flasks, Petri dishes, and microtiter plates, commonly known as test-tube studies. Various applications within biophotonics encompass see-through imaging, internal imaging, spectromolecular analysis, surface imaging, microscopy, light-based therapies, biosensors, and more, with broad utility across sectors such as diagnostics, therapeutics, testing, and related domains.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The biophotonics market research report is one of a series of new reports from The Business Research Company that provides biophotonics market statistics, including biophotonics industry global market size, regional shares, competitors with a biophotonics market share, detailed biophotonics market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. This biophotonics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biophotonics market size has grown rapidly in recent years. It will grow from $83.26 billion in 2024 to $92.07 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to medical imaging advancements, disease diagnosis and monitoring, life sciences research, optical sensing and spectroscopy, laser and light source innovations.
The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $147.84 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to personalized medicine, precision agriculture, global health initiatives, wearable and mobile health devices, environmental monitoring and safety. Major trends in the forecast period include miniaturization and point-of-care devices, multimodal imaging, optogenetics, machine learning and data analytics, smart imaging probes.
The forecast of 12.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical diagnostics by increasing costs for optical coherence tomography systems and laser surgical tools imported from Japan and Israel, potentially reducing precision in procedures and raising equipment expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The biophotonics market is experiencing significant growth, driven by the rising demand for minimally invasive surgeries. Advances in optical engineering and imaging technologies are playing a key role in enhancing minimally invasive procedures, allowing for real-time visualization of tissue manipulation at remote internal locations. For example, in January 2023, Intuitive Surgical Inc., a leading US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This represents an 18% increase from the 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. The growing number of minimally invasive surgeries performed globally each year is directly contributing to the revenue growth in the biophotonics market.
Anticipated to fuel the biophotonics market's growth is the rising prevalence of chronic conditions. Chronic conditions, characterized by their persistent nature lasting three months or longer, are prevalent worldwide. Biophotonics plays a crucial role in early detection, continuous monitoring, and effective treatment of these conditions, offering non-invasive imaging and diagnostic solutions. This facilitates improved patient outcomes while simultaneously curbing healthcare costs. A September 2022 report from the World Health Organization (WHO) disclosed that chronic diseases are responsible for a significant portion of global mortality, with 74% of all deaths attributed to these conditions. This encompasses a range of chronic diseases, including cardiovascular ailments, cancer, chronic respiratory diseases, and diabetes. Hence, the biophotonics market's growth is spurred by the increasing incidence of chronic conditions.
A notable trend driving the biophotonics market is the introduction of advanced techniques in the field of biotechnology. An exemplary development comes from a team of scientists at the University of St. Andrews in Scotland, who devised a fluorescence microscopy technique. This innovative method allows for the imaging of delicate biological samples with minimal damage, particularly in neuroscience and biomedicine applications. Such low-impact optical techniques are anticipated to revolutionize the realm of biomedicine in the near future. As a result, the biophotonics market is witnessing a growing emphasis on novel and cutting-edge techniques.
Leading companies in the biophotonics market are focusing on developing advanced technological solutions, such as cutting-edge computational tools, to improve imaging precision, enhance diagnostics, and support personalized medicine. Advanced computational tools are specialized software and algorithms designed to analyze complex data from fields like medical imaging and molecular diagnostics. By leveraging machine learning and AI, these tools increase the accuracy and efficiency of biophotonics applications. For example, in July 2023, FOXO Technologies Inc., a US-based biotechnology company, launched bioinformatics services aimed at transforming epigenetic data analysis. These services offer a comprehensive platform designed to meet the needs of clients in academia, healthcare, and the pharmaceutical industry. Key features include the processing and analysis of raw DNA methylation microarray data, along with advanced analyses such as epigenome-wide association studies (EWAS) and AI-driven epigenetic biomarker development.
In May 2024, Bruker Corporation, a US-based manufacturing company, acquired NanoString Technologies for $392.6 million. This acquisition will strengthen Bruker's capabilities in spatial biology, particularly with their nCounter Analysis System, which enables high-sensitivity and precision profiling of gene and protein expression. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.
Major companies operating in the biophotonics market include Thermo Fisher Scientific Inc., OpGen Inc., NU Skin Enterprises Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co, Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments PLC, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Impedimed Ltd., Bioptics Inc.
North America was the largest region in the biophotonics market in 2024. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biophotonics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biophotonics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biophotonics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biophotonics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.